Since its founding in 2018, Commerce & Finance Law Offices has made strong in-roads into the Hong Kong market, leveraging very effectively off the firm’s mainland China offices to provide cohesive ‘solutions-oriented advice’ to issuers and underwriters listing on the HKEX. Founding partner Eric Chow is ’technical and responsive’, and has been involved in a number of high-profile healthcare listings alongside the ‘hands-on’ Brandon Chow.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- 'The team provides solutions-oriented advice.'
- 'Eric Chow is technical and responsive.'
- 'Brandon Chow is hands on and ready to provide viable solutions to issues in the IPO deal.'
- 'Winnie Tang is an up and coming lawyer that always provides timely and practical advice to deal with listing issues.'
Kernmandanten
- Concord Healthcare Group Co., Ltd.
- China Securities (International) Corporate Finance Company Limited
- China Merchants Securities (HK) Co., Limited
- Beijing Luzhu Biotechnology Co., Ltd.
- CEB International Capital Corporation Limited
- Aidigong Maternal & Child Health Limited
- Immunotech Biopharm Ltd.
- China Nonferrous Mining Corporation Limited (HKEx: 1258)
Highlight-Mandate
Advised Concord Healthcare Group Co. on its $82.9m global offering and IPO of H-shares on the Main Board of the Hong Kong Stock Exchange.
Advised the joint sponsors on the $32.05m global offering and IPO of H-shares of Pu’er Lancang Ancient Tea Co. on the Main Board of the Hong Kong Stock Exchange.
Advised Beijing Luzhu Biotechnology Co on its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Eric Chow
Weitere Kernanwält*innen
Liu Ning; Terence Lau; Brandon Chow; Winnie Tang